Am Usif10y Gbph (INFB) ニュース

Dang, he shoulda done all that in texas then.

Something amazing is gonna happen here!

How to KEEP bashers!! Respond to them!
Basher posts are like cheese in a mousetrap, and you are the mouse. They smile with glee for every response they get, and anyone that responds to THOSE posts.
If everyone put them on ignore, they would move on. Learn to use your ignore buttons an

Talk about a disaster's investment AMRN will 'for now' be hard to beat !

Besides that - a good Christmas to everyone 🙂

As "valuation" of AMRN is right now - we are basically in an 'all win situation' - so lets see what 2025 will bring. Where we are cant contin

Just saying if the geomagnetic technology got financed with $Millions that would be very huge.

What you consider tip top due diligence I consider mark bait.

How many billions of shares have been diluted into the new circus show?

Is it approaching 19 billion now?

Check A. For Yes:

Check B. For No:

I was looking at the GVSI Twitter feed and this is pretty funny. Anyone that believes in Sharp deserves to lose their investment.

@GeorgeASharp
On February 6, 2024, $GVSI announced that it had enter into a non-binding Term Sheet for the acquisition of a privately owned Blockch

38m bidding. Biggest bid in a long time🚀

LOL!!!

A whopping $3800 that someone just lost in this scam.

Desperate pumping.

The average time for a medical device to go through an FDA clinical trial can vary significantly depending on the device's risk level, but generally takes several years with the process including preclinical research, clinical trials, submission of data to the FDA, and review by the agency before ma

http://archive.fast-edgar.com/20241223/AP2XE22CZC2232Z22223224ZD5WPZJ92B262/

Like one study showing benefit in activities of daily living but not cognition and the other showing benefit in cognition but not ADL's? They were consistent in percent dropouts due to tolerability.

Wasn't the ADL miss in the Phase 2b/3 trial primarily due to the inclusion of mild-onl

I wonder if they made a mistake and filed a FS instead of a RS. This is a very odd scenario here. It's not impossible, I mean, if the company is doing good.

TCRX: TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank

TScan Therapeutics, Inc.
New non-dilutive structure replaces existing convertible facility maturing in 2026, and extends loan maturity to 2029

NVDA Top Bearish Flow – Close
By: Peter DiCarlo | December 23, 2024

• Top Bearish Flow – Close

TSLA – $-42.78M
CVX – $-17.33M
PFE – $-10.58M
NVO – $-10.11M
BABA – $-9.77M

pbs.twimg.com/media/Gfg0BP0XgAAr-YM

Did You Buy the Dip? Yes I bought the Dip.

No comment. The public can decide for themselves.

That's laughable.

Have a great week!

When Y'all gon learn I'm above your Pay grade!!

$3.01 at close December 23/24

lol

fake ...show us proof its fake .. not much going on again...what a bunch of low lives..lmao hahahhaha https://investorshub.advfn.com/uimage/uploads/2024/12/23/pzkkhScreenshot_20241223_181924_X.jpg

Lol

NVDA Top Bullish Flow – Close
By: Peter DiCarlo | December 23, 2024

• Top Bullish Flow – Close

NVDA – $50.04M
FSLR – $10.64M
AMGN – $10M
JNJ – $9M
AVGO – $8.84M

pbs.twimg.com/media/GfgzwUVWsAAo_Az?format=pn

All are welcome my friend!!! Gl to us all! $HLLK

Not surprising, Doc326 two cubicles over remains at 1-2% until he receives his next script.